RESUMO
Objetivo: Evaluar las preferencias y satisfacción de los pacientes con asma grave, relacionadas con el lugar de administración de fármacos biológicos subcutáneos: hospital, centro de salud y domicilio, durante la pandemia COVID-19. Métodos: Estudio observacional, descriptivo y transversal que analizó, mediante una encuesta telefónica realizada del 23 al 27 de noviembre de 2020, las preferencias y el grado de satisfacción con la administración de fármacos biológicos subcutáneos en pacientes asmáticos atendidos en la consulta de Alergología de un Hospital General. Resultados: Respondieron la encuesta 33 pacientes, edad media 51,5 años, 57,6% mujeres. Un 57,6% de los pacientes se administraron los fármacos (omalizumab, mepolizumab y benralizumab) en su domicilio, 21,2% en el Hospital de Día y en el Centro de Salud, respectivamente. Los motivos para la administración fuera del hospital fueron la comodidad y evitar el contagio por virus SARS-CoV-2 (30,7%).Tras la pandemia, los pacientes preferían continuar con la dispensación y autoadministración domiciliaria del biológico y tener consultas médicas presenciales. El grado de satisfacción fue 9,7 (escala 0 a 10). Conclusiones: Los pacientes prefieren autoadministrarse en su domicilio los fármacos biológicos para el AG con el apoyo de la dispensación domiciliaria de éstos, mostrando un alto grado de satisfacción por la comodidad que les aporta. Finalizada la pandemia, demandan que las visitas médicas sean presenciales pero desean continuar autoadministrándose el fármaco tras su dispensación domiciliaria por el Servicio de Farmacia. (AU)
Objective: To assess preferences and satisfaction of patients with severe asthma about the place of administration of subcutaneous biological drugs: hospital, health center and home, during the COVID-19 pandemic. Methods: Observational, descriptive and cross-sectional study that analyzed, from November 23 to 27, 2020, through a telephone survey, the preferences and degree of satisfaction with the administration of subcutaneous biological drugs in asthmatic patients treated in the Allergology consultation of a General Hospital. Results: A total of 33 patients responded to the survey, the mean age was 51.5 years, 57.6% were women. The patients that received subcutaneous biological drugs (omalizumab, mepolizumab and benralizumab) at home were 57,6%, at the Day Hospital and at the Health Center 21,2 %, in both cases. The reasons for the administration outside the hospital were comfort and to avoid the spread of the SAR-CoV-2 virus (30.7%). After the pandemic, patients prefer home deliveries, self-administration and face-to-face medical consultations. The degree of satisfaction with the treatment was very high. Conclusions: Patients prefer to self-administer biological drugs for GA at home with the support of their home dispensing, showing a high degree of satisfaction with the comfort it provides. Once the pandemic is over, they demand that medical visits be face-to-face but they want to continue self-administering the drug after it is dispensed at home by the Pharmacy Service. (AU)
Assuntos
Humanos , Masculino , Feminino , Adulto , Satisfação do Paciente/estatística & dados numéricos , Asma/terapia , Produtos Biológicos/administração & dosagem , Produtos Biológicos/uso terapêutico , Tratamento Domiciliar , Pandemias , Infecções por Coronavirus/epidemiologia , Inquéritos e QuestionáriosAssuntos
Dermatite Alérgica de Contato , Dermatite de Contato , Hipersensibilidade , Acrilatos/efeitos adversos , Alérgenos , Canfanos/efeitos adversos , Dermatite Alérgica de Contato/diagnóstico , Dermatite Alérgica de Contato/etiologia , Glucose , Humanos , Hipersensibilidade/complicações , Testes do Emplastro/efeitos adversosAssuntos
Alérgenos/administração & dosagem , Dessensibilização Imunológica/métodos , Hipersensibilidade a Ovo/epidemiologia , Proteínas Dietéticas do Ovo/administração & dosagem , Esofagite Eosinofílica/epidemiologia , Eosinófilos/patologia , Administração Oral , Adolescente , Alérgenos/efeitos adversos , Criança , Pré-Escolar , Comorbidade , Dessensibilização Imunológica/efeitos adversos , Hipersensibilidade a Ovo/terapia , Proteínas Dietéticas do Ovo/efeitos adversos , Feminino , Humanos , Imunoglobulina E/sangue , Lactente , Masculino , Estudos Prospectivos , Espanha/epidemiologiaRESUMO
No disponible
Assuntos
Humanos , Masculino , Feminino , Lactente , Pré-Escolar , Criança , Adolescente , Alérgenos/administração & dosagem , Dessensibilização Imunológica/métodos , Hipersensibilidade a Ovo/epidemiologia , Proteínas Dietéticas do Ovo/administração & dosagem , Esofagite Eosinofílica/epidemiologia , Eosinófilos/patologia , Administração Oral , Alérgenos/efeitos adversos , Comorbidade , Dessensibilização Imunológica/efeitos adversos , Hipersensibilidade a Ovo/terapia , Proteínas Dietéticas do Ovo/efeitos adversos , Imunoglobulina E/sangue , Estudos Prospectivos , Espanha/epidemiologiaAssuntos
Anafilaxia/induzido quimicamente , Albumina Sérica Humana/efeitos adversos , Adenocarcinoma/tratamento farmacológico , Anafilaxia/sangue , Anafilaxia/diagnóstico , Anafilaxia/imunologia , Neoplasias do Colo/tratamento farmacológico , Humanos , Tolerância Imunológica , Imunoglobulina E/sangue , Testes Imunológicos , Masculino , Pessoa de Meia-Idade , PlasmaRESUMO
No disponible
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Hipersensibilidade Imediata/induzido quimicamente , Hipersensibilidade a Drogas/diagnóstico , Brometo de Butilescopolamônio/efeitos adversos , Anafilaxia/diagnóstico , Doença das Coronárias/classificação , Teste de Degranulação de Basófilos , Testes IntradérmicosRESUMO
Introduction: Cow's milk and egg are the most frequent causes of food allergy in the first years of life. Treatments such as oral immunotherapy (OIT) have been investigated as an alternative to avoidance diets. No clinical practice guides on the management of OIT with milk and egg are currently available. Objectives: To develop a clinical guide on OIT based on the available scientific evidence and the opinions of experts. Methods: A review was made of studies published in the period between 1984 and June 2016, Doctoral Theses published in Spain, and summaries of communications at congresses (SEAIC, SEICAP, EAACI, AAAAI), with evaluation of the opinion consensus established by a group of experts pertaining to the scientific societies SEICAP and SEAIC. Results: Recommendations have been established regarding the indications, requirements and practical aspects of the different phases of OIT, as well as special protocols for patients at high risk of suffering adverse reactions. Conclusions: A clinical practice guide is presented for the management of OIT with milk and egg, based on the opinion consensus of Spanish experts (AU)
No disponible
Assuntos
Humanos , Hipersensibilidade Alimentar/terapia , Imunoterapia/métodos , Dessensibilização Imunológica/métodos , Padrões de Prática Médica , Hipersensibilidade a Leite/terapia , Hipersensibilidade a Ovo/terapia , Imunoterapia Sublingual/métodosRESUMO
Introduction: Cow's milk and egg are the most frequent causes of food allergy in the first years of life. Treatments such as oral immunotherapy (OIT) have been investigated as an alternative to avoidance diets. No clinical practice guides on the management of OIT with milk and egg are currently available. Objectives: To develop a clinical guide on OIT based on the available scientific evidence and the opinions of experts. Methods: A review was made of studies published in the period between 1984 and June 2016, Doctoral Theses published in Spain, and summaries of communications at congresses (SEAIC, SEICAP, EAACI, AAAAI), with evaluation of the opinion consensus established by a group of experts pertaining to the scientific societies SEICAP and SEAIC. Results: Recommendations have been established regarding the indications, requirements and practical aspects of the different phases of OIT, as well as special protocols for patients at high risk of suffering adverse reactions. Conclusions: A clinical practice guide is presented for the management of OIT with milk and egg, based on the opinion consensus of Spanish experts (AU)
No disponible
Assuntos
Humanos , Hipersensibilidade a Ovo/terapia , Hipersensibilidade a Leite/terapia , Dessensibilização Imunológica , Hipersensibilidade Alimentar/terapia , Imunoterapia/métodos , Padrões de Prática MédicaRESUMO
INTRODUCTION: Cow's milk and egg are the most frequent causes of food allergy in the first years of life. Treatments such as oral immunotherapy (OIT) have been investigated as an alternative to avoidance diets. No clinical practice guides on the management of OIT with milk and egg are currently available. OBJECTIVES: To develop a clinical guide on OIT based on the available scientific evidence and the opinions of experts. METHODS: A review was made of studies published in the period between 1984 and June 2016, Doctoral Theses published in Spain, and summaries of communications at congresses (SEAIC, SEICAP, EAACI, AAAAI), with evaluation of the opinion consensus established by a group of experts pertaining to the scientific societies SEICAP and SEAIC. RESULTS: Recommendations have been established regarding the indications, requirements and practical aspects of the different phases of OIT, as well as special protocols for patients at high risk of suffering adverse reactions. CONCLUSIONS: A clinical practice guide is presented for the management of OIT with milk and egg, based on the opinion consensus of Spanish experts.
Assuntos
Alérgenos/uso terapêutico , Dessensibilização Imunológica/métodos , Hipersensibilidade a Ovo/terapia , Proteínas do Ovo/uso terapêutico , Hipersensibilidade a Leite/terapia , Proteínas do Leite/uso terapêutico , Administração Oral , Alérgenos/imunologia , Animais , Bovinos , Contraindicações , Hipersensibilidade a Ovo/imunologia , Proteínas do Ovo/imunologia , Prova Pericial , Humanos , Tolerância Imunológica , Hipersensibilidade a Leite/imunologia , Proteínas do Leite/imunologia , Guias de Prática Clínica como Assunto , EspanhaRESUMO
INTRODUCTION: Cow's milk and egg are the most frequent causes of food allergy in the first years of life. Treatments such as oral immunotherapy (OIT) have been investigated as an alternative to avoidance diets. No clinical practice guides on the management of OIT with milk and egg are currently available. OBJECTIVES: To develop a clinical guide on OIT based on the available scientific evidence and the opinions of experts. METHODS: A review was made of studies published in the period between 1984 and June 2016, Doctoral Theses published in Spain, and summaries of communications at congresses (SEAIC, SEICAP, EAACI, AAAAI), with evaluation of the opinion consensus established by a group of experts pertaining to the scientific societies SEICAP and SEAIC. RESULTS: Recommendations have been established regarding the indications, requirements and practical aspects of the different phases of OIT, as well as special protocols for patients at high risk of suffering adverse reactions. CONCLUSIONS: A clinical practice guide is presented for the management of OIT with milk and egg, based on the opinion consensus of Spanish experts.
Assuntos
Alérgenos/uso terapêutico , Dessensibilização Imunológica/métodos , Proteínas do Ovo/uso terapêutico , Hipersensibilidade Alimentar/terapia , Proteínas do Leite/uso terapêutico , Administração Oral , Alérgenos/imunologia , Protocolos Clínicos , Cálculos da Dosagem de Medicamento , Proteínas do Ovo/imunologia , Prova Pericial , Hipersensibilidade Alimentar/imunologia , Humanos , Proteínas do Leite/imunologia , Guias de Prática Clínica como Assunto , EspanhaRESUMO
BACKGROUND AND OBJECTIVE: Cow milk and egg are the most frequent causes of food allergy in the first years of life. Oral immunotherapy (OIT) has been investigated as an alternative to avoidance diets. No clinical practice guidelines on the management of OIT with milk and egg are currently available. Objectives: To develop clinical guidelines for OIT based on available scientific evidence and the opinions of experts. METHODS: A review was made of studies published between 1984 and June 2016, doctoral theses published in Spain, summaries of communications at scientific meetings (SEAIC, SEICAP, EAACI, and AAAAI), and the consensus of opinion established by a group of experts from the scientific societies SEICAP and SEAIC. RESULTS: Recommendations were established regarding the indications, requirements and practical aspects of the different phases of OIT, as well as special protocols for patients at high risk of adverse reactions. CONCLUSIONS: Clinical practice guidelines based on the consensus reached between Spanish experts are presented for the management of OIT with milk and egg.
Assuntos
Alérgenos/uso terapêutico , Dessensibilização Imunológica/métodos , Hipersensibilidade a Ovo/terapia , Hipersensibilidade a Leite/terapia , Administração Oral , Humanos , Guias de Prática Clínica como Assunto , EspanhaRESUMO
BACKGROUND AND OBJECTIVE: Cow milk and egg are the most frequent causes of food allergy in the first years of life. Oral immunotherapy (OIT) has been investigated as an alternative to avoidance diets. No clinical practice guidelines on the management of OIT with milk and egg are currently available. Objectives: To develop clinical guidelines for OIT based on available scientific evidence and the opinions of experts. METHODS: A review was made of studies published between 1984 and June 2016, doctoral theses published in Spain, summaries of communications at scientific meetings (SEAIC, SEICAP, EAACI, and AAAAI), and the consensus of opinion established by a group of experts from the scientific societies SEICAP and SEAIC. RESULTS: Recommendations were established regarding the indications, requirements and practical aspects of the different phases of OIT, as well as special protocols for patients at high risk of adverse reactions. CONCLUSIONS: Clinical practice guidelines based on the consensus reached between Spanish experts are presented for the management of OIT with milk and egg.